trustmebro.to/r/…
✓ checked
trust me, bro:
here is the receipt.
the claim

Oral pre-exposure prophylaxis (PrEP) is a tool to reduce mother-to-child transmission of HIV.

the verdict
SUPPORTED
the evidence backs this
Recorded sources
3 sources for · 0 against

Counts group repeated records of the same source within each side. They do not measure evidence strength or source independence.

Is it true that oral pre-exposure prophylaxis (PrEP) is a tool to reduce mother-to-child transmission of HIV?

Yes. Oral pre-exposure prophylaxis (PrEP) is a key biomedical tool used to prevent maternal HIV acquisition during pregnancy and the postpartum period, thereby reducing the risk of mother-to-child transmission.

Verdict: SUPPORTED · 3 sources for, 0 against · Last checked

The analysis

The retrieved literature consistently supports the role of PrEP in preventing maternal HIV acquisition during pregnancy and breastfeeding, which directly helps eliminate vertical transmission. Papers explicitly highlight PrEP as a vital tool for keeping women free of HIV during these vulnerable periods.

Evidence for · 3
2023
PrEP during pregnancy is highlighted as playing an important role in preventing HIV acquisition and subsequent vertical transmission.
Get citation
Yang, L., Cambou, M., & Nielsen-Saines, K. (2023). The End Is in Sight: Current Strategies for the Elimination of HIV Vertical Transmission. doi.org. https://doi.org/10.1007/s11904-023-00655-z

See more details
More for · 2
2026
Long-acting PrEP is discussed as an effective tool for HIV prevention among pregnant and lactating women to mitigate postnatal transmission risks.
Get citation
MS, K., CG, B., MD, K., S, M., HD, C., VK, P., D, P., F, S., M, H., F, C., C, W., & V, M. (2026). Breastmilk transfer of cabotegravir and infant safety outcomes in mothers on cabotegravir for HIV prevention in Lilongwe, Malawi: A protocol for an observational pharmacokinetic study, CABMILK Study.. doi.org. https://doi.org/10.12688/wellcomeopenres.25966.2

2025
HIV pre-exposure prophylaxis (PrEP) is recognized as a crucial biomedical tool to keep mothers free of HIV and eliminate vertical transmission.
Get citation
Rutstein, S., Lucas, V. A., Hosseinipour, M., Herce, M. E., Edwards, J. K., Cassidy, C., Villiera, J., Kamanga, F., Chagomerana, M., Oosterhout, J. V. v., Chikuse, E., Rambiki, E., Thawani, A., Malewezi, B., Makhupula, L., Udedi, C., Mbulaje, P., Matoga, M., Kumwenda, W., Mvalo, T., Bula, A., Nkhalamba, L., Mofolo, I., Chinula, L., Thonyiwa, V., Kumwenda, O., Chisema, M., Hoffman, I. F., Miller, W. C., Go, V. F., Pence, B. W., Squibb, M. A., & Saidi, F. (2025). Leveraging infant visit PrEP screening INtegration & tasK shifting to improve post-partum HIV prevention in Malawi (LINK): a cluster-randomized trial evaluation of a postpartum HIV prevention package among breastfeeding women in Malawi. doi.org. https://doi.org/10.1186/s12913-025-13133-6

What does the evidence say?

The retrieved literature consistently supports the role of PrEP in preventing maternal HIV acquisition during pregnancy and breastfeeding, which directly helps eliminate vertical transmission. Papers explicitly highlight PrEP as a vital tool for keeping women free of HIV during these vulnerable periods.

Anyone with this link can read the claim and its public receipt, including any personal information in that text. Open permanent receipt.
Check your own claim
Challenge the receipt
Requests are recorded for review. This does not start an automatic check or guarantee a response time.

See the evidence timeline

Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.

This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work